Dr. Vigmostad's research expertise is in fluid mechanics, mechanobiology, and medical devices. As a professor in biomedical engineering, she specializes in medical device design, and several design projects she has mentored have resulted in new IP filings and start-ups. She teaches regulatory affairs and design thinking, and has worked with start-up companies performing customer discovery and evaluating product-market fit.

Dr. Henry has a PhD from MIT specializing in Cancer Cell Biology, and has over 25 years of experience in cancer research. He is the Deputy Director for Research at the Holden Comprehensive Cancer Center at The University of Iowa, and is the cancer biologist who made the initial discoveries leading to SynderBio’s core technology. He also has experience in cancer personalized medicine as a Senior Scientist with Millennium Pharmaceuticals.

Dr. Cable has extensive executive experience in startup technology businesses. He served as VP and Chief Technology Officer for Xenogen Corporation from 1998-2004, marketing a device-based research technology for animal bioluminescent and fluorescent imaging. As one of its first employees at startup, he participated in its growth to over 200 employees and $31M in revenue.